The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InThe global market for cystoscopy and ureteroscopy devices is forecasted to reach US$ 729.30 million by 2031, driven by the rising adoption of minimally invasive surgical procedures. Major industry players, including Stryker Corp, Teleflex Inc, and Coloplast Corp, are positioned to capitalize on this expansion. A primary growth catalyst identified is the integration of Artificial Intelligence (AI) into endoscopic imaging, which promises to enhance diagnostic precision. Furthermore, the expansion of healthcare infrastructure in emerging markets is providing significant tailwinds for the sector despite high equipment costs. This growth trajectory reflects increasing global demand for advanced urological solutions. Analysts maintain a bullish outlook for specialized medical device manufacturers as technological advancements continue to reshape the clinical landscape.